MST – Medical Surgery Technologies Ltd., a Yokneam, Israel-based developer of image-guided surgical systems, closed a $12.5m Series C funding round.
The investment was led by Haisco Pharmaceutical Group, a Chinese pharmaceutical manufacturer, with participation from existing investors Triventures, SCP Vitalife Partners, Agate MaC Medical Investments, OurCrowd and Jacobs Investment Company.
The company intends to use the funds for expanding marketing and sales of AutoLap® in the U.S. Europe and China.
Led by Motti Frimer, CEO, MST markets the FDA-cleared and CE-approved AutoLap, an image-guided laparoscope positioning system targeting the minimally invasive surgery market. Based on proprietary image analytic technology platform, AutoLap gives surgeons full and natural control of the surgical procedure with minimal user interaction.
As part of the investment, Haisco will serve as exclusive distributor of AutoLap® in China.